Early Bird

Secure Cash and Transport Industry Stakeholders to Gather at the 2023 SCTA Conference in Chicago

Retrieved on: 
Wednesday, April 12, 2023
Early Bird, Swissôtel, Districts of Zambia, Art, Conference, History, SCTA

PURCELLVILLE, Va., April 12, 2023 /PRNewswire-PRWeb/ -- Early bird registration is now open for the Secure Cash & Transport Association (SCTA) annual conference at the Swissotel Chicago, September 13-15, 2023. This year is the SCTA's 11th annual event and will center on the topic of "Leading Through Adversity." The conference features informative sessions, networking opportunities, and exhibits and is designed to support the Association's mission to protect, strengthen, and unite the cash-in-transit and cash-servicing industries. Early bird registration offers discount pricing to members and non-members until July 28, 2023.

Key Points: 
  • The 11th SCTA Conference will occur September 13-15, 2023 at the Swissotel Chicago with Alison Levine delivering the keynote address.
  • Registration for the 2023 event is now open with Early Bird rates ending July 28, 2023.
  • PURCELLVILLE, Va., April 12, 2023 /PRNewswire-PRWeb/ -- Early bird registration is now open for the Secure Cash & Transport Association (SCTA) annual conference at the Swissotel Chicago, September 13-15, 2023.
  • Today, the SCTA also proudly announces its keynote speaker for the 2023 event, Alison Levine.

Saranas Reaches Midpoint for Enrollment in Clinical Trial Assessing the Utility of Early Bleed Detection in Patients Undergoing Mechanical Circulatory Support

Retrieved on: 
Monday, March 27, 2023
Cardiology, Surgery, Health, FDA, Medical Devices, Health Technology, Clinical Trials, Other Health, CRF, Bleeding, De novo, Morristown Medical Center, Classification, BARC, Henry Ford Health, Structural heart disease, PCI, Incidence, Henry Ford, Patient, Impella, TAVR, Early Bird, Research, The Early Bird, MCS, Early, EVAR, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, III, Aortic stenosis, Food, Safety, Medical device, Birth control

The Early Bird Bleed Monitoring System is the first and only FDA-approved bleed detection system.

Key Points: 
  • The Early Bird Bleed Monitoring System is the first and only FDA-approved bleed detection system.
  • Patients undergoing complex high-risk PCI with mechanical circulatory support (MCS) via Impella and transfemoral arterial approach are enrolled as study participants.
  • “This is an important milestone in our efforts to continue building clinical evidence to support the utility of the Early Bird device.
  • The Saranas Early Bird Bleed Monitoring System is the first and only FDA-approved device for real-time monitoring of endovascular bleed complications.

Opera goes live with generative AI tools in Desktop browser and Opera GX

Retrieved on: 
Wednesday, March 22, 2023
WhatsApp, Early access, UI, GX, Synthetic media, ChatGPT, Win, Czajka, Research, Translation, Early Bird, OPRA, AI, News, Medical device, Music, Telegraphy, Linux, Opera (web browser), Mac

This marks the first stage of Opera's Browser AI, with plans to move to stage two featuring its own browser AI engine in the near future

Key Points: 
  • This marks the first stage of Opera's Browser AI, with plans to move to stage two featuring its own browser AI engine in the near future
    OSLO, Norway, March 22, 2023 /PRNewswire/ -- As generative AI tools continue to reshape the digital landscape, Opera [NASDAQ: OPRA] is integrating AI capabilities into its desktop browsers.
  • Shipping today in Opera and Opera GX are AI Prompts and sidebar integration of the popular GPT-based services ChatGPT and ChatSonic.
  • Today's release marks the first stage of Opera's Browser AI - the second stage will be built on Opera's own GPT-based browser AI engine.
  • Generative AI tools are available in early access in Opera (Win, Mac, and Linux) and Opera GX (Win and Mac).

Oculis to Ring Nasdaq Stock Market Opening Bell in Celebration of its Successful Listing

Retrieved on: 
Wednesday, March 22, 2023
Retina, Glaucoma, DED, New Board, LSP, AON, DME, Coronavirus Scientific Advisory Board, OCS, Diabetic retinopathy, Inflammation, EDT, Pain, Telecanthus, Patient, Ophthalmology, Neuro, Early Bird, Disease, Pharmaceutical industry, Management, Pecten oculi

ZUG, Switzerland, and BOSTON, March 22, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, announces that it will ring the Nasdaq opening bell today to celebrate its public listing on the Nasdaq Stock Market earlier this month.

Key Points: 
  • ZUG, Switzerland, and BOSTON, March 22, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, announces that it will ring the Nasdaq opening bell today to celebrate its public listing on the Nasdaq Stock Market earlier this month.
  • Oculis is advancing multiple late clinical-stage product candidates in key areas of medical need.
  • The Nasdaq opening bell ringing will take place at 9:30am EDT, signifying the start of the day’s trading session.
  • Riad Sherif MD, CEO of Oculis, commented: “We are ringing the opening bell today in celebration of Oculis’ public listing, which would not have been possible without the great support of our investors, our partners and the dedication of our employees.

Oculis Announces US Public Listing on NASDAQ

Retrieved on: 
Friday, March 3, 2023
Credit Suisse, BofA Securities, Neuro, SA, Wardwell, Patient, Ophthalmology, Telecanthus, PIPE, DED, Pivotal, Early Bird, SVB, PwC, Coronavirus Scientific Advisory Board, Upsizing (database), AON, Cooley, Retina, Neuro-ophthalmology, SVB Securities, Shearman & Sterling, LSP, Arctica Finance, DME, Probability, Prospectus, Acquisition, Risk, Maples Group, Physician, Pharmaceutical industry, Fine chemical, Management, Security (finance), Pecten oculi

From today, Oculis’ shares will trade on the Nasdaq Stock Market under the ticker symbol “OCS”.

Key Points: 
  • From today, Oculis’ shares will trade on the Nasdaq Stock Market under the ticker symbol “OCS”.
  • Upon closing, Oculis had a pro-forma enterprise value of approximately $220 million and a cash balance exceeding $117 million, prior to payment of final transaction costs.
  • Riad Sherif MD, CEO of Oculis, commented: “Listing on the Nasdaq Stock Market is a major corporate milestone for Oculis and its investors.
  • It is a confirmation of the potential of Oculis’ pipeline to bring significant value for patients, physicians and investors.

Saranas Appoints Mike MacKinnon as CEO

Retrieved on: 
Monday, February 27, 2023
Biotechnology, Health, Surgery, Medical Devices, Aortic stenosis, Patient safety, Physician, FIH, Partner, Risk, Acquisition, MCS, Standard of care, FDA, EVAR, Patient, CT, Trial of the century, Atherectomy, Bleeding, Medtech, Growth, Innovation system, Hypertension, Private equity, Philips, Volcano, Early Bird, TAVR, Birth control, Multistrada Arah Sarana

Saranas® Inc., a medical device company focused on improving patient outcomes through early detection and monitoring of internal bleeding complications, today announced the hiring of seasoned medtech executive, Mike MacKinnon, as Chief Executive Officer.

Key Points: 
  • Saranas® Inc., a medical device company focused on improving patient outcomes through early detection and monitoring of internal bleeding complications, today announced the hiring of seasoned medtech executive, Mike MacKinnon, as Chief Executive Officer.
  • “We are delighted to have Mike join and lead Saranas as we continue our mission establishing early bleed detection and monitoring as the standard of care for patients undergoing endovascular procedures,” commented Dan Wolterman, Saranas Board Chairman.
  • He originally joined Volcano as part of the acquisition of AtheroMed in June 2014, which he led as CEO.
  • “I am excited to join Saranas at this important time as the company continues to build commercial momentum and clinical evidence for the Early Bird,” stated Mike MacKinnon, CEO of Saranas.

NCPDP Announces Robin Farmanfarmaian as Keynote Speaker for its 2023 Annual Technology & Business Conference, "The Great Race to Close Gaps in Care"

Retrieved on: 
Wednesday, February 22, 2023
Organization, White, Health, Pharmacy, Robin, Department of Defence, United States Department of Defense, Aryl hydrocarbon receptor, VR, Diagnosis, Patient, Organ, The Patient, Database, Silicon, White House, Morphine, Early Bird, Knowledge, Great race, Meeting, Drug discovery, Quality of life, Book, The Westin Kierland Resort & Spa, Conference, NCPDP, Cryopreservation, Pharmaceutical industry, Health care

SCOTTSDALE, Ariz., Feb. 22, 2023 /PRNewswire-PRWeb/ -- NCPDP announced today Robin Farmanfarmaian, speaker, author, and tech entrepreneur, will give an important closing keynote address about the future of healthcare, technology, and patient empowerment at NCPDP's 2023 Annual Technology & Business Conference, "The Great Race to Close Gaps in Care", May 8-10, 2023, at the Westin Kierland Resort & Spa in Scottsdale, Arizona. NCPDP's national annual conference draws more than 700 attendees from across the healthcare industry, including technical, business, and executive representatives from health plans, pharmacy benefit managers, retail and independent pharmacies, specialty pharmacies, long-term care providers, healthcare consultants, technology vendors, pharmaceutical manufacturers, wholesale drug distributors, database management organizations and others.

Key Points: 
  • Medical Tech Futurist, Robin Farmanfarmaian, Will Engage and Inspire Conference Goers in a Powerful Call to Action to Close Gaps in Healthcare.
  • SCOTTSDALE, Ariz., Feb. 22, 2023 /PRNewswire-PRWeb/ -- NCPDP announced today Robin Farmanfarmaian, speaker, author, and tech entrepreneur, will give an important closing keynote address about the future of healthcare, technology, and patient empowerment at NCPDP's 2023 Annual Technology & Business Conference, "The Great Race to Close Gaps in Care" , May 8-10, 2023, at the Westin Kierland Resort & Spa in Scottsdale, Arizona.
  • Robin Farmanfarmaian, who lives, breathes, and works on the cutting edge of all things medical technology, has an incredible story to share.
  • For real-time updates before and during the event, follow us at http://twitter.com/ncpdp or join the discussion using NCPDP's 2023 Annual Technology & Business Conference hashtag: #NCPDP23.

Orb Labs Raises $4.5M Seed, Led by Bain Capital Crypto, to Solve Blockchain Interoperability Once and for All

Retrieved on: 
Tuesday, February 14, 2023
Technology, Other Professional Services, Web3, Blockchain, Finance, Apps, Applications, Banking, Professional Services, Digital Cash Management, Digital Assets, Software, Cryptocurrency, Crowdfunding, Security, Consumer Electronics, Crypto, Veteran, Decentralized finance, Partner, Perseverance, Ecosystem, Princeton University, Heart, Marketing, Early Bird, Research, Uniswap, Ethereum, Labs

Orb Labs, a blockchain interoperability company, is excited to announce its $4.5M seed round led by Bain Capital Crypto, with participation from Shima Capital, 6th Man Ventures, Aves Lair, Newman Capital, Modular Capital, and SevenX Ventures.

Key Points: 
  • Orb Labs, a blockchain interoperability company, is excited to announce its $4.5M seed round led by Bain Capital Crypto, with participation from Shima Capital, 6th Man Ventures, Aves Lair, Newman Capital, Modular Capital, and SevenX Ventures.
  • Through its best-in-class solution for blockchain interoperability, Orb Labs prioritizes efficiency and security, qualities that are critical for developers building user-friendly cross-chain applications.
  • “Our team is excited to power the next wave of blockchain interoperability by providing gas-efficient, fast, and trust-minimized messaging protocols.
  • Orb Labs is building cross-chain messaging protocols and tools for developers to build cross-chain applications.

Educational Crypto Soars Despite Market Conditions - SOWL Token

Retrieved on: 
Wednesday, December 7, 2022
Love, Media, Female, SOWL, Education, Growth, 2009 Davis Cup, Social media, Mother, Early Bird, Cryptocurrency, Telegraphy

Baltimore, Maryland--(Newsfile Corp. - December 7, 2022) - SOWL Token , the educational crypto start-up run by Cecil County native Megan Hallett launched last month despite market turmoil in the crypto sector.

Key Points: 
  • Baltimore, Maryland--(Newsfile Corp. - December 7, 2022) - SOWL Token , the educational crypto start-up run by Cecil County native Megan Hallett launched last month despite market turmoil in the crypto sector.
  • SOWL has been one of the crypto industry's best performers in the past month, in a time where the market overall has been down.
  • SOWL is also expanding into the P2E (Play 2 Earn) market where users can play educational games and earn free SOWL tokens that can be redeemed for cash.
  • Additionally, SOWL Token provides free virtual education to kids across the world through the company's "The SOWL Purpose" initiative.

Announcing the 2023 MIT Sloan CIO Symposium: Driving Digital Resilience in a Turbulent World

Retrieved on: 
Thursday, December 15, 2022
Online, Operational technology, WarnerMedia, CIO, Early Bird, Equifax, CISO-FM, Melissa, Environment, CIOS, MIT, Learning, Virtual community, CarMax, The Clift Royal Sonesta Hotel, CDO, Symposium, Disney Parks, Experiences and Products, Seating assignment, MIT Sloan School of Management, Online community, Multimedia, Steward Health Care System, McDermott, Government, Williams Club, Liberty Mutual, Organization, Management, Wolfram Mathematica

CAMBRIDGE, Mass., Dec. 15, 2022 /PRNewswire/ -- The MIT Sloan CIO Symposium is pleased to announce the 20th anniversary edition of the nation's premier CIO conference. Global CIOs are invited to learn, network and attend the in-person event, which will explore the theme: Driving Digital Resilience in a Turbulent World, and will be held at the Royal Sonesta Hotel in Cambridge, Massachusetts on May 15-16, 2023.

Key Points: 
  • Global CIOs are invited to learn, network and attend the in-person event, which will explore the theme: Driving Digital Resilience in a Turbulent World, and will be held at the Royal Sonesta Hotel in Cambridge, Massachusetts on May 15-16, 2023.
  • Registration is now open for the 2023 MIT Sloan CIO Symposium.
  • The MIT Sloan CIO Symposium is the premier global conference for CIOs and digital business executives.
  • The MIT Sloan CIO Symposium is organized and developed by the MIT Sloan Boston Alumni Association.